Skip to content
MedsAcross

Medicine

Flexbumin 12.5 g/50 mL injection

Albumin human · Intravenous · Takeda Pharmaceuticals
Available on requestPrescription onlyUS FDA

Flexbumin 12.5 g/50 mL injection is a prescription medicine containing Albumin human for intravenous use, marketed by Takeda Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Protect from freezing. Room temperature: not to exceed 25°C (77°F).

Key facts

Active ingredient (INN)
Albumin human
Brand
Flexbumin
Strength
12.5 g/50 mL
Dosage form
Injection
Route
Intravenous
Packs
12 bags of 50 mL
Marketing authorisation holder
Takeda Pharmaceuticals
Manufacturer
Takeda Pharmaceuticals
Origin register
US FDA, United States
Storage
Protect from freezing. Room temperature: not to exceed 25°C (77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3002.12Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
9 August 2002
Identifiers
RxCUI 1741375, 1741380, 1742401 +1DailyMed set ID bdb4e167-27a2-4b50-b245-43df9cd535cbNDC 0944-0493Application BLA101452

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
12 bag in 1 carton / 50 mL in 1 bag0944-0493-01Takeda Pharmaceuticals9 August 2002

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 31 December 1997Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Albumin human 12.5 g/50 mL injection.

Compare all 7

Other strengths and forms of Albumin human

Clinical summary

Albumin human is a human serum albumin indicated for hypovolemia and Hypoalbuminemia, among other approved uses. It is available as injection for intravenous use. MedsAcross supplies Albumin human for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Albumin human

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Flexbumin 12.5 g/50 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.